Objective: To investigate recovery of medical decision-making capacity (MDC) over the first year following traumatic brain injury (TBI).
Following traumatic brain injury (TBI), individuals are confronted with numerous medical problems and treatment decisions during acute hospitalization, rehabilitation, and over the course of long-term recovery. Medical issues may include managing medications, following advance directives, or treating orthopedic injuries and secondary complications. 1, 2 Therefore, it is of clinical importance to determine whether the cognitive and emotional deficits associated with TBI impair a person's medical decision-making capacity (MDC), 3 which includes the ability to comprehend and recall pertinent information and then make logical decisions based upon that information.
Previous studies by our group have investigated MDC using the Capacity to Consent to Treatment Instrument (CCTI) in patients with uncomplicated mild TBI (mTBI), complicated mild TBI (cmTBI), and moderate/severe TBI (msevTBI). 1, [4] [5] [6] These studies found impairments at time of injury in MDC in cmTBI and msevTBI groups, with partial recovery of MDC at 6 months. However, to date, longitudinal studies of longer-term recovery of MDC in TBI have not been conducted.
In the present study, we longitudinally investigated MDC over a 12-month period in healthy controls and in persons with TBI representing a range of TBI severity: mTBI, cmTBI, and msevTBI. We hypothesized that persons in all 3 TBI groups would show MDC impairment at baseline. Given that many people who sustain a TBI improve cognitively over the course of the first year, we hypothesized that improvements in MDC would occur over the course of the 12-month study period. However, we expected recovery to be limited for those who sustained msevTBI. Patients were excluded if they had received substance abuse treatment within 1 year of enrollment (per patient/family report) or had a preexisting diagnosed CNS disorder, developmental disorder, or severe psychiatric disorder. Individuals with a prior mTBI or cmTBI were included if their previous injury occurred at least 1 year before enrollment. Persons with a previous msevTBI were excluded.
Healthy controls were recruited through local advertisements and selected to match participants with TBI on demographic variables of age, sex, ethnicity, and education. Controls were excluded if they had been diagnosed with a psychiatric disorder (except mild depression), substance abuse, cerebrovascular disease, or other neurologic disease. None of the controls was taking medications known to affect cognition.
Procedures. TBI severity level (i.e., mTBI, cmTBI, msevTBI) was assigned using diagnostic criteria from TBI Model Systems (table e-1 at Neurology.org) and has been well-described previously. [7] [8] [9] [10] [11] [12] [13] [14] All TBIs resulted from a closed head injury and individuals with penetrating brain injuries (e.g., gunshot wound) were excluded from the study.
Consistent with the TBI Model System protocol, 15 the average time from date of brain injury to baseline assessment was 32 days (SD 12 days). Participants were also assessed at 6 and 12 months postinjury. Sixteen of the controls and 26 of the patients with TBI did not complete all 3 visits due to the following reasons: scheduling problems (6%), not interested in participating (25%), skipped visit caused by being outside of study window for follow-up (6%), illness (6%), excluded for poor effort (6%), and unknown (50%).
At all 3 visits participants completed the CCTI and a comprehensive battery of neuropsychological and psychological measures. Cross-sectional results from the neuropsychological test battery have been reported separately. 16 Standard protocol approvals, registrations, and patient consents. We obtained written informed consent from each participant or in some cases their legal representative or a family member. The study procedures followed protocol and accord with the ethical standards of the UAB Institutional Review Board, which approved this study.
Measures. Consent capacity measure. The CCTI 17 is a psychometric instrument with established reliability and validity used to assess MDC. 17, 18 The CCTI contains 2 clinical vignettes that are presented in both oral and written formats. Each vignette presents a hypothetical medical problem (A, neoplasm; B, cardiovascular disease) and symptoms followed by the presentation of the risks and benefits of 2 alternative treatment options. After vignette presentation, the written format is removed, and participants respond to standardized oral questions designed to assess the following 4 core consent standards derived from the legal and medical literature 17, 19 : expressing a treatment choice (expressing choice), appreciating the personal consequences of a treatment choice (appreciation), providing rational reasons for a treatment choice (reasoning), and understanding the treatment situation, available treatment choices, and respective risks/benefits of the treatment choices (understanding).
A fifth standard measures the ability to make a reasonable treatment choice (reasonable choice). 17 As the term "reasonable" is interpreted with some degree of subjectivity, reasonable choice is not a clinically accepted consent standard and is considered to be experimental.
Trained research assistants administered and scored the CCTI according to well-operationalized criteria. 17 Responses to the CCTI questions were recorded on audiotape and transcribed to ensure scoring accuracy. Research assistants who scored the protocols were blinded to participant group status and the study investigators were not involved in either CCTI administration or scoring.
Data analysis. Demographic variables were analyzed using oneway analysis of variance (age, years of education, Glasgow Coma Scale [GCS] score, Galveston Orientation and Amnesia Test [GOAT] score) or Pearson x 2 tests (sex, race). Significant omnibus tests were followed with Games-Howell or 2 3 2 x 2 tests.
We employed generalized estimating equations (GEE) with independent correlation matrices to assess the longitudinal effects of TBI severity on performance on the appreciation, reasoning, and understanding CCTI standards at baseline, 6 months, and 12 months following injury. GEE is an extension of generalized linear model approaches that accounts for the correlated nature of longitudinal data. 20 Moreover, GEE utilizes data from all participants (rather than just completers) and provides more robust estimates in the presence of missing data. 21 For ordinal variables (appreciation, reasoning), a cumulative logistic link function was used, and for normally distributed, continuous variables (understanding), an identity link was used in the model. The main effects of TBI severity and time were explored along with their interaction, using the healthy control group and baseline visit as the reference. Almost the entire study sample (approximately 95%) obtained perfect scores on CCTI expressing choice and reasonable choice. Due to this lack of variability, formal statistics were not conducted on these standards.
We also examined capacity impairment ratings (no impairment, mild/moderate impairment, severe impairment) for each participant with TBI by comparing their performance to that of healthy controls. For appreciation, reasoning, and understanding standards, a no impairment rating was defined as a score no more than 1.5 SDs below the control mean on that standard; a mild/ moderate impairment rating as a score between 1.5 SDs and 2.5 SDs below the control mean; and a severe impairment rating as a score more than 2.5 SDs below the control mean. For expressing choice, a no impairment rating was defined as a score of 4, a mild/moderate impairment rating as a score of 3, and a severe impairment rating as a score of #2. For reasonable choice, the only 2 possible impairment ratings were no impairment (1) and impairment (0).
Assignment of ratings is useful in categorizing the extent of MDC impairment and has been implemented in previous studies assessing capacity in clinical samples. 17, 22, 23 While these impairment ratings have scientific and clinical value, they are used experimentally for scientific purposes and are not representative of participants' actual legal or clinical competency status.
The assigned significance level for analyses was p , 0.05.
RESULTS
Demographic and sample characteristics. Table 1 lists the causes of TBI for the patient sample. Table 2 presents demographic/clinical variables for healthy controls and all TBI groups. Although the omnibus test for age revealed a significant group difference, subsequent post hoc analyses did not reach significance despite cmTBI participants being older by approximately a decade. Additionally, the mTBI group had a greater proportion of nonwhite participants than those with cmTBI (x 2 5 4.791, p 5 0.029) or msevTBI (x 2 5 8.759, p 5 0.003). As expected, the msevTBI group had lower baseline GCS and GOAT scores than both mTBI and cmTBI groups (all p , 0.001).
TBI group and control performance on the CCTI. Table 4 presents the odds ratios (appreciation, reasoning) or differences in raw scores (understanding) to compare the TBI group and healthy controls at each timepoint. Mild TBI. In comparison to healthy controls, patients with mTBI had poorer appreciation and understanding immediately following injury. However, by 6 months postinjury, those with mTBI did not differ from controls on either standard. The ability to provide a rational reason for treatment choice was not impaired in patients with mTBI in the first year following injury relative to those without head injury.
Complicated mild TBI. At baseline, those with cmTBI perform worse than controls on appreciation, reasoning, and understanding. Six months after injury, only understanding was impaired relative to controls. The 2 groups do not differ on any standard 12 months postinjury. Moreover, the mTBI and cmTBI groups do not differ from each other on appreciation, reasoning, or understanding at any timepoint (all p . 0.05).
Moderate/severe TBI. Compared to healthy controls, patients with msevTBI have poorer appreciation, reasoning, and understanding at baseline and at 6 months following injury. Although appreciation is similar to that of healthy controls by 12 months, those with msevTBI continue to demonstrate impaired performance relative to controls on reasoning and understanding with little to no improvement in scores between months 6 and 12.
Of note, the repeated measures analyses were conducted with and without covariates for race and age. Inclusion of these covariates did not appreciably change the results. Thus, only results from the unadjusted analyses are reported.
Capacity impairment ratings. Table 5 presents capacity impairment ratings (intact, mild/moderate impairment, severe impairment) by TBI group across the CCTI consent standards of appreciation, reasoning, and understanding at all 3 timepoints. Although approximately 18% of people with msevTBI exhibited an impaired ability to make a reasonable treatment choice at baseline, impairment on either expressing choice or reasonable choice did not exceed 10% for any other TBI group or at any other timepoint. Thus, these 2 CCTI consent standards were not included in table 5.
Mild TBI. At baseline, a third of participants with mTBI had impaired ratings (mild/moderate or severe) for appreciation and a fifth of participants had impaired understanding. However, less than 20% of participants with mTBI continued to demonstrate impairment at 6 and 12 months on these consent standards.
Complicated mild TBI. Less than half of the cmTBI group exhibited impaired appreciation (39%), reasoning (30%), and understanding (48%) at baseline. At 6 months, a quarter and a little over a third of the cmTBI group was still impaired on understanding and appreciation, respectively. However, impairment did not exceed 14% on any consent standard at 12 months.
Moderate/severe TBI. At baseline, over half of the msevTBI group exhibited impaired reasoning and appreciation, with impaired performance on understanding approaching 80%. Although msevTBI Table 1 Causes of traumatic brain injury in the study sample (n 5 111) participants improved on all 3 standards at 6 months, a large proportion remained impaired a year after injury: 17% for appreciation, 25% for reasoning, and 50% for understanding. DISCUSSION We used a standardized performance measure and 5 consent standards to investigate MDC over a 12-month period in persons with a range of TBI severity. Our study found that a great majority of all 3 TBI groups (mTBI, cmTBI, and msevTBI) were capable of expressing and making reasonable treatment choices (expressing choice, reasonable choice). In contrast, all 3 TBI groups exhibited significant impairment and differential Abbreviations: cmTBI 5 complicated mild traumatic brain injury; msevTBI 5 moderate/severe traumatic brain injury; mTBI 5 mild traumatic brain injury.
Values are mean 6 SD. improvement on the 3 more complex consent standards of appreciation, reasoning, and understanding over the first year following injury. Results are discussed separately for each TBI group. As expected, we found that subtle impairments in cognitively complex aspects of MDC were present in many people with acute mTBI. However, most of these individuals exhibited intact consent capacity after 6 months. These results highlight the temporal relationship between cognitive and MDC recovery in TBI. For example, previous studies have noted that people with mTBI perform commensurately to healthy controls on most cognitive measures within 3-6 months following injury. [24] [25] [26] [27] In addition, we noted in a previous study that the group effects of mTBI on MDC did not always transfer to the individual level. 6 Although the mTBI group as a whole performed statistically equal to healthy controls, Table 5 Number (%) of participants with traumatic brain injury (TBI) exhibiting impaired decision-making capacity across TBI group and time Abbreviations: cmTBI 5 complicated mild traumatic brain injury; msevTBI 5 moderate/severe traumatic brain injury; mTBI 5 mild traumatic brain injury. a number of individuals who had sustained mTBI continued to show some level of MDC impairment a year after injury. This finding is also consistent with the literature on cognitive recovery in mTBI, as a subsample of those with mTBI may continue to experience cognitive impairment after most have recovered. [24] [25] [26] [27] [28] Factors such as age, education, comorbid medical and psychiatric issues, and substance abuse history have been implicated as affecting cognitive recovery 29, 30 and, thus, likely influence individual differences in MDC recovery as well.
The current results demonstrate that the cmTBI subgroup experiences more initial MDC impairment and slower recovery than those with mTBI, but over 1 year approaches full recovery. These results are consistent with previous literature that has noted that structural brain abnormalities seen in complicated mild head injuries are associated with worse cognitive and functional outcome than those with mTBI, despite the fact that these 2 patient groups share similar clinical characteristics (Glasgow Coma Scale score, loss of consciousness, and post-traumatic amnesia). 31, 32 Although our study found subtle differences in MDC between groups over the first 6 months, by 1 year postinjury, the cmTBI and mTBI groups are virtually indistinguishable from each other or from healthy controls, with fewer than 20% of patients in both groups demonstrating impairment on any CCTI standard at this timepoint.
As outlined in our previous study, 5 the msevTBI group demonstrated the most severe MDC impairments at baseline. Although the majority of MDC recovery in the msevTBI group took place over the first 6 months following recovery, all 3 complex consent standards remained below the level of control performance. There appeared to be some individuals who continued to recover past 6 months on the appreciation standard, but this group experienced little to no improvement on reasoning or understanding and remained impaired for a year following injury. These findings support the results from our earlier longitudinal study with a separate msevTBI group and indicate a need for continual monitoring of MDC in those with more severe head injuries for at least a year postinjury. 1 However, cognitive improvement has been found to occur in a subset of individuals with msevTBI more than a year after their injury. 33 Thus, it remains possible that some people who sustained msevTBI will continue to show MDC recovery after the initial year following injury.
It is important to consider the underlying neuropsychological and neurobehavioral correlates of the MDC changes we have described. Although an assessment of neuropsychological predictors of MDC outcome at 12 months postinjury is beyond the scope of the current study, previous work by our group 16 has demonstrated that performance on measures of verbal memory (list and story learning), academic skills (word reading and written arithmetic), and verbal fluency (letter and category fluency) predicted performance on appreciation, reasoning, and understanding at 1 month postinjury. These cognitive predictors varied slightly by injury severity. Practitioners should note that diminished abilities in these cognitive domains, particularly verbal memory, might serve as a red flag for impaired medical decision-making ability in persons with TBI.
A significant proportion of patients with TBI are impaired in their capacity to make medical decisions 1 month after injury, with partial or full recovery during the first year. Recovery generally appears to stabilize after 6 months with limited MDC improvement between 6 and 12 months following injury in all groups. MDC outcome varied according to injury severity. The greatest amount of improvement occurred in patients with msevTBI. However, the msevTBI group still had the worst longitudinal outcome, as they remained impaired in their reasoning and understanding consent abilities at 12 months. Although CCTI performance for the mTBI and cmTBI groups approached that of controls by 6 months, approximately 18% of individuals with mTBI and 13% of those with cmTBI still demonstrated some level of impaired MDC 12 months postinjury. Clinically, the current findings underscore the importance of evaluating MDC soon after injury and over time in all individuals with TBI.
There were several limitations to the current study. First, we were unable to compare individuals with moderate and severe TBI due to insufficient number of moderate injuries. Second, approximately a quarter of our participants did not complete all 3 visits. Although GEE analysis is relatively robust to missing data, future investigations into MDC recovery using larger samples that can better absorb the statistical effect of attrition are needed. Third, studies in this population examining MDC over a longer duration of observation would also provide useful information about longterm outcomes. Finally, individuals may respond differently to the CCTI's hypothetical clinical vignettes than to real-life, personal medical situations, which may trigger emotional aspects of MDC not captured by this measure.
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